MedPath

Charité - Universitätsmedizin Berlin

Charité - Universitätsmedizin Berlin logo
🇩🇪Germany
Ownership
Private
Established
1710-01-01
Employees
10K
Market Cap
-
Website
http://www.charite.de

Clinical Trials

1.1k

Active:147
Completed:495

Trial Phases

6 Phases

Early Phase 1:2
Phase 1:120
Phase 2:115
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (694 trials with phase data)• Click on a phase to view related trials

Not Applicable
374 (53.9%)
Phase 1
120 (17.3%)
Phase 2
115 (16.6%)
Phase 4
45 (6.5%)
Phase 3
37 (5.3%)
Early Phase 1
2 (0.3%)
phase_1_2
1 (0.1%)

Intensive Care Unit-acquired Heart Failure in Critically Ill: the ICU-HF Study

Not yet recruiting
Conditions
Heart Failure
ICUAW
First Posted Date
2025-07-30
Last Posted Date
2025-07-30
Lead Sponsor
Charite University, Berlin, Germany
Target Recruit Count
50
Registration Number
NCT07094425
Locations
🇦🇹

Medical University of Vienna, Vienna, Austria

🇩🇪

Charité - Universitätsmedizin Berlin, Berlin, Germany

Neurobehavioral Mechanisms of Moral Reasoning: an EEG Study in Patients With Borderline Personality Disorder

Completed
Conditions
Borderline Personality Disorder (BPD)
First Posted Date
2025-07-29
Last Posted Date
2025-07-29
Lead Sponsor
Charite University, Berlin, Germany
Target Recruit Count
64
Registration Number
NCT07091409
Locations
🇩🇪

Dep. of Psychiatry, CBF, Berlin, Germany

Post-intensive Care Syndromes in Pregnant Patients With Respiratory Failure and COVID-19 Compared to Non-pregnant Patients With Respiratory Failure and COVID-19

Not yet recruiting
Conditions
COVID-19
Acute Respiratory Distress Syndrome Due to COVID-19
Pregnancy Related
First Posted Date
2025-07-04
Last Posted Date
2025-07-29
Lead Sponsor
Charite University, Berlin, Germany
Target Recruit Count
40
Registration Number
NCT07051967
Locations
🇩🇪

Department of Anesthesiology and Intensive Care Medicine (CCM/CVK), Charité - Universitätsmedizin Berlin, Berlin, Germany

Feasibility of Empowerment Group Therapy on Ukrainian Adult Outpatients

Not Applicable
Recruiting
Conditions
Depression NOS
First Posted Date
2025-07-03
Last Posted Date
2025-07-03
Lead Sponsor
Charite University, Berlin, Germany
Target Recruit Count
55
Registration Number
NCT07048990
Locations
🇺🇦

National Medical University Bogomolets, Kyiv, Ukraine

Effects of the Clinical Application of Traditional, Complementary and Integrative Medicine (TCIM) Procedures During Inpatient Stays in Germany

Recruiting
Conditions
Chronic Disease
First Posted Date
2025-06-27
Last Posted Date
2025-07-09
Lead Sponsor
Charite University, Berlin, Germany
Target Recruit Count
2500
Registration Number
NCT07040475
Locations
🇩🇪

Sozialstiftung Bamberg, Klinikum Bamberg, Bamberg, Germany

🇩🇪

Charité Hochschulambulanz für Naturheilkunde am Immanuel Krankenhaus, Institut für Sozialmedizin, Epidemiologie und Gesundheitsökonomie, Charité - Universitätsmedizin Berlin, Berlin, Germany

🇩🇪

Klinik für Naturheilkunde und Integrative Medizin, KEM, Essen, Germany

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 164
  • Next

News

Simvastatin Fails to Show Antidepressant Benefits in Major Depression and Obesity Trial

A randomized controlled trial of 161 patients with major depressive disorder and obesity found that adding simvastatin to escitalopram provided no additional antidepressant benefits compared to placebo.

Alys Pharmaceuticals Advances First-in-Class Mast Cell-Selective c-Kit Inhibitor ALY-301 to Clinical Trials for Cold Urticaria

Alys Pharmaceuticals has submitted a Clinical Trial Application to Germany's Paul-Ehrlich-Institut for ALY-301, a first-in-class bispecific antibody targeting c-Kit and CD-203c with mast cell selectivity.

PEARLDIVER: Europe-Wide Platform Trial Aims to Accelerate Depression Treatment Development

The PEARLDIVER project, a Europe-wide platform study, will evaluate multiple depression treatments simultaneously using a shared infrastructure.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.